insuline dégludec
insuline dégludec: This substance is used in diabetes management. It acts on blood glucose through a mechanism that depends on the active ingredient. Common uses: type 2 diabetes or insulin needs, metabolic follow-up, and blood-glucose control according to patient profile. This active substance is linked to 5 verified medicine records in SOS DOC for price, form, and reimbursement comparison.
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
| Medicines | Laboratory | Form | Strength | Commercial status | ATC code | Public price | Hospital price | Reimbursement base |
|---|---|---|---|---|---|---|---|---|
| TRESIBA FlexTouch 100 U/ml | LAPROPHAN | Solution injectable | 100 U/ml | Not available in the verified source | A10AE06 | 243,00 MAD | 152,30 MAD | Not available in the verified source |
| TRESIBA FlexTouch 100 U/ml | LAPROPHAN | Solution injectable | 100 U/ml | Not available in the verified source | A10AE06 | 1.040,00 MAD | 761,00 MAD | Not available in the verified source |
| TRESIBA FLEXTOUCH | LAPROPHAN | SOLUTION INJECTABLE EN STYLO PREREMPLI | 200 UI / ML | Non commercialisé / Sans Prix | Not available in the verified source | Not available in the verified source | Not available in the verified source | Not available in the verified source |
| TRESIBA FLEXTOUCH | LAPROPHAN | SOLUTION INJECTABLE EN STYLO PREREMPLI | 200 UI / ML | Non commercialisé / Sans Prix | Not available in the verified source | Not available in the verified source | Not available in the verified source | Not available in the verified source |
| TRESIBA PENFILL | LAPROPHAN | SOLUTION INJECTABLE | 100 UI / ML | Non commercialisé / Sans Prix | Not available in the verified source | Not available in the verified source | Not available in the verified source | Not available in the verified source |